惠升医药健康6个月持有期混合(010405)财务指标
| |
2025-12-31 |
2025-06-30 |
2024-12-31 |
2024-06-30 |
| 本期已实现收益 |
77,444,709.47 |
7,385,896.50 |
-122,740,206.69 |
-78,666,881.55 |
| 本期利润 |
85,090,782.22 |
71,621,637.91 |
-107,589,493.46 |
-141,972,846.22 |
| 加权平均基金份额本期利润 |
0.09 |
0.07 |
-0.10 |
-0.13 |
| 本期加权平均净值利润率(%) |
14.16 |
12.41 |
-16.95 |
-21.02 |
| 本期基金份额净值增长率(%) |
14.26 |
13.06 |
-13.83 |
-18.59 |
| 期末可供分配利润 |
-276,887,733.69 |
-377,786,088.45 |
-422,626,023.57 |
-496,128,972.64 |
| 期末可供分配基金份额利润 |
-0.34 |
-0.41 |
-0.42 |
-0.45 |
| 期末基金资产净值 |
538,355,464.84 |
600,215,187.70 |
578,781,487.20 |
596,961,390.05 |
| 期末基金份额净值 |
0.66 |
0.65 |
0.58 |
0.55 |
| 基金份额累计净值增长率(%) |
-33.96 |
-34.65 |
-42.20 |
-45.39 |
微信公众号
证券之星APP
基本资料
